MACULAR DEGENERATION, AGE-RELATED

Clinical trials for MACULAR DEGENERATION, AGE-RELATED explained in plain language.

Never miss a new study

Get alerted when new MACULAR DEGENERATION, AGE-RELATED trials appear

Sign up with your email to follow new studies for MACULAR DEGENERATION, AGE-RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New eye shot aims to slow blinding eye disease

Disease control Ongoing

This study is testing a new investigational eye injection called BI 771716 against an already approved treatment, pegcetacoplan, for people with geographic atrophy. Geographic atrophy is an advanced form of age-related macular degeneration that causes progressive, permanent visio…

Matched conditions: MACULAR DEGENERATION, AGE-RELATED

Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

MACULAR DEGENERATION, AGE-RELATED

Get alerted when new MACULAR DEGENERATION, AGE-RELATED trials appear

New eye shot aims to slow blinding eye disease